Literature DB >> 29333578

Insulin resistance and bone: a biological partnership.

Caterina Conte1, Solomon Epstein2, Nicola Napoli3,4.   

Abstract

Despite a clear association between type 2 diabetes (T2D) and fracture risk, the pathogenesis of bone fragility in T2D has not been clearly elucidated. Insulin resistance is the primary defect in T2D. Insulin signalling regulates both bone formation and bone resorption, but whether insulin resistance can affect bone has not been established. On the other hand, evidence exists that bone might play a role in the regulation of glucose metabolism. This article reviews the available experimental and clinical evidence on the interplay between bone and insulin resistance. Interestingly, a bilateral relationship between bone and insulin resistance seems to exist that unites them in a biological partnership.

Entities:  

Keywords:  Bone mineral density; Bone turnover markers; Insulin; Obesity; Osteocalcin; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29333578     DOI: 10.1007/s00592-018-1101-7

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  21 in total

1.  Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults.

Authors:  Nicola Napoli; Caterina Conte; Claudio Pedone; Elsa S Strotmeyer; Kamil E Barbour; Dennis M Black; Elizabeth J Samelson; Ann V Schwartz
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.

Authors:  H Zhou; C Li; W Song; M Wei; Y Cui; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2021-01-06       Impact factor: 4.507

3.  Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study.

Authors:  Maryam Kazemi; Brittany Y Jarrett; Stephen A Parry; Anna E Thalacker-Mercer; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

4.  Association between metabolic syndrome and osteoporosis among adults aged 50 years and older: using the National Health Information Database in South Korea.

Authors:  Sang Youl Rhee; Dong Keon Yon; Mi Jung Kwon; Ji Hee Kim; Joo-Hee Kim; Woo Jin Bang; Jung Woo Lee; Bong-Cheol Kwon; Hyo Geun Choi; Chanyang Min
Journal:  Arch Osteoporos       Date:  2022-09-16       Impact factor: 2.879

5.  Hepatocyte growth factor administration increases bone soluble phosphate and alters bone chemical structure in diabetic hypertensive rats.

Authors:  Kamal Awad; Natasha G Boyes; Ramlah Iqbal; Mohamed Ahmed; Adel Mohamed; Pranesh Aswath; Corey R Tomczak; Venu Varanasi
Journal:  J Mater Res       Date:  2021-07-23       Impact factor: 2.909

6.  Weight change and the risk of hip fractures in patients with type 2 diabetes: a nationwide cohort study.

Authors:  S-W Lee; K Han; H-S Kwon
Journal:  Osteoporos Int       Date:  2022-04-19       Impact factor: 5.071

7.  Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes.

Authors:  Alessandra Piccoli; Francesca Cannata; Rocky Strollo; Claudio Pedone; Giulia Leanza; Fabrizio Russo; Valentina Greto; Camilla Isgrò; Carlo Cosimo Quattrocchi; Carlo Massaroni; Sergio Silvestri; Gianluca Vadalà; Tiziana Bisogno; Vincenzo Denaro; Paolo Pozzilli; Simon Y Tang; Matt J Silva; Caterina Conte; Rocco Papalia; Mauro Maccarrone; Nicola Napoli
Journal:  J Bone Miner Res       Date:  2020-10-02       Impact factor: 6.741

Review 8.  Muscle-bone axis in children with chronic kidney disease: current knowledge and future perspectives.

Authors:  Vasiliki Karava; John Dotis; Athanasios Christoforidis; Antonia Kondou; Nikoleta Printza
Journal:  Pediatr Nephrol       Date:  2021-02-03       Impact factor: 3.714

9.  FSH may mediate the association between HbA1c and bone turnover markers in postmenopausal women with type 2 diabetes.

Authors:  Ke-Xi Zha; Zeng-Mei An; Shao-Hong Ge; Jian Cai; Ying Zhou; Rong Ying; Ji Zhou; Tao Gu; Hui Guo; Yan Zhao; Ning-Jian Wang; Ying-Li Lu
Journal:  J Bone Miner Metab       Date:  2022-01-21       Impact factor: 2.626

10.  Effect of the Abnormal Expression of BMP-4 in the Blood of Diabetic Patients on the Osteogenic Differentiation Potential of Alveolar BMSCs and the Rescue Effect of Metformin: A Bioinformatics-Based Study.

Authors:  Chao Liang; Rongxin Sun; Yifan Xu; Wei Geng; Jun Li
Journal:  Biomed Res Int       Date:  2020-06-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.